Domestic markets, new product launches to drive FY22 earnings for Alkem
The mainstay India business continues to do well, with boost coming from covid-led sales. Analysts say that the company has seen a good pick-up in 1QFY22 sales of vitamins/minerals, antacids, antibiotics, pain relief medicines, among others04-06-2021